Prudential Financial
SLRN

Prudential Financial’s ACELYRIN SLRN Stock Holding History

Prudential Financial’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,130
Closed -$44.4K – 2373
2024
Q4 		$44.4K Sell
14,130
-62,600
-82% -$303K ﹤0.01% 2222
2024
Q3 		$378K Buy
76,730
+15,300
+25% +$79K ﹤0.01% 2325
2024
Q2 		$271K Buy
61,430
+14,138
+30% +$66.3K ﹤0.01% 2392
2024
Q1 		$319K Sell
47,292
-31,151
-40% -$237K ﹤0.01% 2315
2023
Q4 		$585K Buy
+78,443
New +$670K ﹤0.01% 2078

Other funds holding SLRN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Prudential Financial's SLRN Position: Q1 2025 in Review

Prudential Financial sold out of ACELYRIN (SLRN) in Q1 2025, closing a stake of 14,130 shares — an estimated $44.4K sold.

Prudential Financial first reported a position in SLRN in Q4 2023 and held it in 5 quarters. The position peaked at $585K in Q4 2023. 105 funds tracked by Wall St. Rank hold SLRN as of Q1 2025.

  • Prudential Financial reported no remaining ACELYRIN position as of Q1 2025 after selling out during the quarter.
  • Prudential Financial sold 14,130 ACELYRIN shares in Q1 2025, an estimated $44.4K.
  • Prudential Financial first reported a position in ACELYRIN in Q4 2023 and held it in 5 quarters.
  • Prudential Financial's ACELYRIN position peaked at $585K in Q4 2023.
  • 105 funds tracked by Wall St. Rank held ACELYRIN as of Q1 2025.

Based on Prudential Financial's 13F filing for Q1 2025, filed 13 May 2025.